MedTrace Logo

B.Brilliant Revelation Comparision Study

NCT07067788 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-24

No results posted yet for this study

Summary

This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices

Conditions

  • Breast Cancer Screening

Interventions

DIAGNOSTIC_TEST

Breast Imaging

Intervention using an FDA-approved mammogram machine.

Sponsors & Collaborators

Principal Investigators

  • Brian S Englander, MD · Pennsylvania Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2026-07-30
Completion
2027-01-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07067788 on ClinicalTrials.gov